285 - Division for Cancer Pharmacology – Young Investigators Symposium and Susan B. Horwitz Award Lecture in Cancer Pharmacology

Session Chair(s)

• Lori Hazlehurst

  West Virginia University

• Daniel Gustafson

  Colorado State University

This session will highlight oral presentations by young scientists doing research in cancer pharmacology who were selected from the submitted abstracts. Additionally, the session will feature the inaugural lecture by the winner of the 2022 Susan B. Horwitz Award in Cancer Pharmacology.

Presentations:

• 1:00 PM – 1:03 PM

  Introduction
• 1:03 PM – 1:18 PM

  A β-catenin-TCF-sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer
  

  Presenting Author: Jeffrey Rappaport – Thomas Jefferson University
• 1:18 PM – 1:33 PM

  Inhibition of Core Binding Factor Transcriptional Complex Provides a Novel Pharmacological Target for Osteosarcoma
  

  Presenting Author: Dayn Godinez – University of California, Davis
• 1:33 PM – 1:48 PM

  HUNK Phosphorylates Rubicon to Support Autophagy, Promoting Tumorigenesis in HER2+ Breast Cancer
  

  Presenting Author: Tinslee Dilday – Indiana University School of Medicine
• 1:48 PM – 2:03 PM

  Inhibition of PRMT5 Disrupts Cell Cycle Progression and DNA Damage Signaling, Revealing a Potential Novel Combination Therapy for Pancreatic Cancer
  

  Presenting Author: Lishu He – Medical College of Wisconsin
• 2:03 PM – 2:55 PM

  Susan Band Horwitz Award Lecture in Cancer Pharmacology
• 2:55 PM – 3:00 PM

  Conclusion